{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T21:22:29Z","timestamp":1784928149205,"version":"3.55.0"},"reference-count":33,"publisher":"FapUNIFESP (SciELO)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq Bras Endocrinol Metab"],"published-print":{"date-parts":[[2013,8]]},"abstract":"<jats:p>OBJECTIVE: This study sought to examine corticosteroidogenic enzyme activities in normo- and hyperandrogenic polycystic ovary syndrome (PCOS) patients. SUBJECTS AND METHODS: This cohort study included 81 patients with biochemical hyperandrogenism and 41 patients with normal androgen levels. Enzyme activities were assessed according to the serum steroid product\/precursor ratios at baseline and after adrenal stimulation. RESULTS: At baseline, in the delta 4 (\u03944) pathway, hyperandrogenic patients showed greater 17-hydroxylase and 17,20 lyase activities in converting progesterone (P4) into 17-hydroxyprogesterone (17-OHP4) and 17-hydroxypregnenolone (17-OHPE) into androstenedione (A) (p = 0.0005 and p = 0.047, respectively) compared to normoandrogenic patients. In the delta 5 (\u03945) pathway, the 17-hydroxylase and 17,20 lyase enzymes showed similar activities in both groups. Hyperandrogenic patients presented lower 21-hydroxylase, lower 11\u03b2-hydroxylase (p = 0.0001), and statistically significant increases in 3\u03b2-hydroxysteroid dehydrogenase II (3\u03b2-HSDII) activities (p &lt; 0.0001). Following tetracosactrin stimulation, only the 17,20 lyase activity remained up-regulated in the \u03944 pathway (p &lt; 0.0001). CONCLUSION: Hyperandrogenic patients had higher 17,20 lyase activity, both at baseline and after adrenal stimulation. Greater conversion of dehydroepiandrosterone (DHEA) into A with normal conversion of 17-OHPE to 17-OHP4 in hyperandrogenic PCOS patients indicated different levels of 3\u03b2-HSDII activity in adrenal cells, and hyperandrogenic patients had lower 11\u03b2-hydroxylase and 21-hydroxylase activities.<\/jats:p>","DOI":"10.1590\/s0004-27302013000600005","type":"journal-article","created":{"date-parts":[[2013,9,11]],"date-time":"2013-09-11T14:06:46Z","timestamp":1378908406000},"page":"437-444","source":"Crossref","is-referenced-by-count":18,"title":["New insights into steroidogenesis in normo- and hyperandrogenic polycystic ovary syndrome patients"],"prefix":"10.1590","volume":"57","author":[{"given":"Sebasti\u00e3o Freitas de","family":"Medeiros","sequence":"first","affiliation":[{"name":"Universidade Federal de Mato Grosso, Brazil; Julio Muller University Hospital, Brazil; Tropical Institute of Reproductive Medicine and Menopause, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c2ngelo Barrionuevo","family":"Gil-Junior","sequence":"additional","affiliation":[{"name":"Julio Muller University Hospital, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacklyne Silva","family":"Barbosa","sequence":"additional","affiliation":[{"name":"Tropical Institute of Reproductive Medicine and Menopause, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9rico Duarte","family":"Isa\u00edas","sequence":"additional","affiliation":[{"name":"Julio Muller University Hospital, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rcia Marly Winck","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Tropical Institute of Reproductive Medicine and Menopause, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1365-2265.1997.2321049.x","article-title":"Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome","volume":"47","author":"Gilling-Smith C","year":"1997","journal-title":"Clin Endocrinol."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.fertnstert.2003.07.008","article-title":"Adrenocortical hyperresponsiveness to corticotrophin in polycystic ovary syndrome patients with adrenal androgen excess","volume":"81","author":"Moran C","year":"2004","journal-title":"Fertil Steril."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/BF03346454","article-title":"Increased clearance of cortisol by 5beta-reductase in a subgroup of women with adrenal hyperandrogenism in polycystic ovary syndrome","volume":"32","author":"Gambineri A","year":"2009","journal-title":"J Endocrinol Invest."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril."},{"key":"ref5","series-title":"Polycystic ovary syndrome","first-page":"377","volume-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","author":"Zawadski JK","year":"1992"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline","volume":"91","author":"Azziz R","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz R","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"key":"ref8","first-page":"541","article-title":"Adrenal androgen participation in the polycystic ovary syndrome","volume":"32","author":"Gil-Junior AB","year":"2010","journal-title":"Rev Bras Gynecol Obstet."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1210\/er.2003-0030","article-title":"Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones","volume":"25","author":"Payne AH","year":"2004","journal-title":"Endocr Rev","ISSN":"https:\/\/id.crossref.org\/issn\/0163-769X","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0029-7844(95)00065-Y","article-title":"Reassessment of adrenal androgen secretion in women with polycystic ovary syndrome","volume":"85","author":"Carmina E","year":"1995","journal-title":"Obstet Gynecol."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0015-0282(16)53510-9","article-title":"Dysregulation of cytochrome P450c 17 alpha as a cause of polycystic ovary syndrome","volume":"53","author":"Rosenfield RL","year":"1990","journal-title":"Fertil Steril."},{"key":"ref12","first-page":"670","article-title":"The frequency of late-onset 21-hydroxylase and 11\u03b2-hydroxilase deficiency in women with polycystic ovary syndrome","volume":"137","author":"Sahin Y","year":"1997","journal-title":"Hum Reprod."},{"key":"ref13","first-page":"603","article-title":"The impact of estrogen on adrenal androgen sensitivity and secretion in polycystic ovary syndrome","volume":"80","author":"Ditkoff EC","year":"1995","journal-title":"J Clin Endocrinol Metab."},{"key":"ref14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000050360","article-title":"Adrenal contribution to polycystic ovary syndrome","volume":"10","author":"Bayoumy HA","year":"2001","journal-title":"Med Princ Pract."},{"key":"ref15","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1210\/jcem-57-2-320","article-title":"Genotyping steroid 21-hydroxylase deficiency: hormonal reference data","volume":"57","author":"New ML","year":"1983","journal-title":"J Clin Endocrinol Metab."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.steroids.2007.08.009","article-title":"Helpful diagnostic markers of steroidogenesis for defining hyperandrogenemia in hirsute women","volume":"73","author":"Willenberg HS","year":"2008","journal-title":"Steroids."},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fertnstert.2005.09.066","article-title":"Selecting controls is not selecting \"normals\": design and analysis issues for studying the etiology of polycystic ovary syndrome","volume":"86","author":"Bloom MS","year":"2006","journal-title":"Fertil Steril."},{"key":"ref18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.steroids.2010.10.010","article-title":"Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatography-tandem mass spectrometry","volume":"76","author":"Rothman MS","year":"2011","journal-title":"Steroids."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1210\/jc.2007-2053","article-title":"A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs","volume":"93","author":"Escobar-Morreale HF","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"ref20","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1056\/NEJM198903023200904","article-title":"Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome","volume":"320","author":"Barnes RB","year":"1989","journal-title":"N Engl J Med."},{"key":"ref21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1530\/eje.0.1470473","article-title":"A comparison between the effects of low dose (1 \u00b5g) and standard dose (250 \u00b5g) ACTH stimulation tests on adrenal P450c17\u03b1 enzyme activity in women with polycystic ovary syndrome","volume":"147","author":"\u00c7olak R","year":"2002","journal-title":"Eur J Endocrinol."},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1074\/jbc.273.6.3158","article-title":"Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer","volume":"273","author":"Auchus RJ","year":"1998","journal-title":"J Biol Chem."},{"key":"ref23","first-page":"881","article-title":"Insulin infusion amplifies 17 alpha-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20 lyase activity","volume":"81","author":"Moghetti P","year":"1996","journal-title":"J Clin Endocrinol Metab."},{"key":"ref24","first-page":"6:2498","article-title":"Steroid 17 alpha-hidroxylase and 17,20-lyase activities of P450c 17: contributions of serine 106 and P450 reductase","volume":"132","author":"Lin D","year":"1993","journal-title":"Endocrinology."},{"key":"ref25","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1210\/jcem.87.2.8240","article-title":"Genetics of serum dehydroepiandrosterone sulfate and its relationship to insulin in a population-based cohort of twin subjects","volume":"87","author":"Nestler JE","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"key":"ref26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.steroids.2006.05.005","article-title":"Steroidogenic alterations and adrenal androgen excess in PCOS","volume":"71","author":"Doi SAR","year":"2006","journal-title":"Steroids."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1210\/jcem-60-3-428","article-title":"Late-onset adrenal steroid 3 beta-hydroxysteroid dehydrogenase deficiency a cause of hirsutism in pubertal ans postpubertal women","volume":"60","author":"Pang S","year":"1985","journal-title":"J Clin Endocrinol Metab."},{"key":"ref28","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0015-0282(16)48741-8","article-title":"Adrenocorticotrophic hormone testing in idiopathic hirsutism and polycystic ovarian disease: a test of limited usefulness","volume":"44","author":"Cobin RH","year":"1985","journal-title":"Fertil Steril."},{"key":"ref29","first-page":"6:2611","article-title":"Newly proposed hormonal criteria via genotypic proof for type II 3beta-hydroxylase deficiency","volume":"87","author":"Lutfallah C","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.fertnstert.2009.06.025","article-title":"The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia","volume":"94","author":"Pall M","year":"2010","journal-title":"Fertil Steril."},{"key":"ref31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1507\/endocrj.K07-053","article-title":"The prevalence of non-classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in greek women with hirsutism and polycystic ovary syndrome","volume":"55","author":"Trakakis E","year":"2008","journal-title":"Endocr J."},{"key":"ref32","first-page":"400","article-title":"Adrenal androgen excess in women: lack of a role for 17-hydroxylase and 17, 20-lyase dysregulation","volume":"80","author":"Azziz R","year":"1995","journal-title":"J Clin Endocrinol Metab."},{"issue":"8","key":"ref33","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1373\/clinchem.2006.068445","article-title":"Development and performance evaluation of a tandem mass spectrometry assay for 4 adrenal steroids","volume":"52","author":"Kushnir MM","year":"2006","journal-title":"Clin Chem","ISSN":"https:\/\/id.crossref.org\/issn\/0009-9147","issn-type":"print"}],"container-title":["Arquivos Brasileiros de Endocrinologia &amp; Metabologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abem\/v57n6\/05.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T13:58:01Z","timestamp":1688479081000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-27302013000600005&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0004-27302013000600005"],"URL":"https:\/\/doi.org\/10.1590\/s0004-27302013000600005","relation":{},"ISSN":["0004-2730"],"issn-type":[{"value":"0004-2730","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}